Mercator Medical S.A. (WSE:MRC)
Poland · Delayed Price · Currency is PLN 58.00
+1.00 (1.75%)
Nov 4, 2026, 3:50 PM CET
Mercator Medical Ratios and Metrics
Market cap in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 538 | 351 | 467 | 396 | 525 | 1,033 | |
Market Cap Growth | 35.19% | -24.78% | 17.85% | -24.58% | -49.12% | -76.89% |
Enterprise Value | 387 | 168 | 107 | 44 | 87 | 556 |
Last Close Price | 57.00 | 36.70 | 46.29 | 40.19 | 45.22 | 88.89 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 7.99 | 12.29 | 10.47 | - | - | 2.31 |
Forward PE | - | 2.02 | 2.02 | 2.02 | 2.02 | 2.02 |
PS Ratio | 0.85 | 0.61 | 0.86 | 0.85 | 0.97 | 0.60 |
PB Ratio | 0.56 | 0.39 | 0.51 | 0.46 | 0.52 | 0.90 |
P/TBV Ratio | 0.57 | 0.40 | 0.53 | 0.48 | 0.53 | 0.91 |
P/FCF Ratio | 254.86 | - | - | - | - | 3.17 |
P/OCF Ratio | 11.51 | 9.37 | - | - | 12.88 | 2.05 |
PEG Ratio | - | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.61 | 0.29 | 0.20 | 0.09 | 0.16 | 0.32 |
EV/EBITDA Ratio | 5.09 | 19.11 | - | - | - | 1.16 |
EV/EBIT Ratio | 7.85 | - | - | - | - | 1.20 |
EV/FCF Ratio | 182.21 | - | - | - | - | 1.71 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.34 | 2.61 | - | - | - | 0.01 |
Debt / FCF Ratio | 12.04 | - | - | - | - | 0.02 |
Net Debt / Equity Ratio | -0.15 | -0.20 | -0.27 | -0.37 | -0.41 | -0.46 |
Net Debt / EBITDA Ratio | -1.98 | -20.07 | 52.14 | 5.97 | 8.25 | -1.10 |
Net Debt / FCF Ratio | -70.63 | 13.14 | 2.90 | 8.21 | 6.08 | -1.63 |
Asset Turnover | 0.60 | 0.56 | 0.54 | 0.46 | 0.46 | 1.34 |
Inventory Turnover | 1.89 | 2.02 | 2.18 | 2.05 | 1.95 | 3.18 |
Quick Ratio | 2.98 | 3.14 | 3.69 | 5.49 | 8.19 | 4.96 |
Current Ratio | 4.89 | 5.19 | 6.46 | 7.46 | 11.63 | 6.87 |
Return on Equity (ROE) | 7.16% | 3.23% | 4.88% | -2.44% | -17.71% | 40.66% |
Return on Assets (ROA) | 2.87% | -0.92% | -1.47% | -4.49% | -3.94% | 22.45% |
Return on Invested Capital (ROIC) | 5.75% | -2.17% | -3.88% | -13.02% | -12.40% | 77.41% |
Return on Capital Employed (ROCE) | 4.90% | -1.60% | -2.50% | -8.30% | -7.30% | 40.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 12.52% | 8.14% | 9.56% | -4.96% | -36.09% | 43.27% |
FCF Yield | 0.39% | -3.83% | -18.15% | -9.88% | -13.11% | 31.59% |
Dividend Yield | 1.16% | 1.77% | 3.37% | - | - | - |
Buyback Yield / Dilution | 1.68% | 1.80% | 2.02% | 1.91% | 3.47% | 3.88% |
Total Shareholder Return | 2.86% | 3.57% | 5.39% | 1.91% | 3.47% | 3.88% |